Save your place

Sign in to WhoBought

Please try again later.

Ken Griffin's AbbVie Inc. (ABBV) position

Yes: as of Q1 2026, Ken Griffin holds 490K shares of ABBV worth $106M (0.1% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$106M
Shares held
490K
% of portfolio
0.1%
Est. average buy price (i)
$188.59
Quarter-end price
$216.53

Estimated trade prices

Average price in quarters with purchases
$162.87
Average prices in quarters with sales
  • Q1 2026: $221.79 (243K shares sold)
  • Q4 2025: $227.94 (2.4M shares sold)
  • Q3 2025: $203.66 (147K shares sold)
  • Q1 2024: $172.34 (523K shares sold)
  • Q4 2023: $145.79 (2.6M shares sold)
  • Q2 2023: $146.64 (333K shares sold)
  • Q4 2022: $153.33 (44K shares sold)
  • Q3 2022: $143.50 (40K shares sold)
  • Q2 2022: $152.80 (413K shares sold)
  • Q1 2022: $145.26 (5K shares sold)
  • Q4 2021: $118.13 (149K shares sold)
  • Q2 2021: $112.62 (964K shares sold)

ABBV price vs Griffin's position

Dates
$100$150$200$250$30020222023202420252026Added 959K shares (563.4%) · Q3 2021. Average closing price $114.27 · Price range $106.40–$120.78959KsharespurchasedSold 149K shares (13.2%) · Q4 2021. Average closing price $118.13 · Price range $107.43–$135.93149KsharessoldSold 5K shares (0.5%) · Q1 2022. Average closing price $145.26 · Price range $131.98–$163.755KsharessoldSold 413K shares (42.3%) · Q2 2022. Average closing price $152.80 · Price range $137.62–$174.96413KsharessoldSold 40K shares (7.0%) · Q3 2022. Average closing price $143.50 · Price range $134.21–$153.9340KsharessoldSold 44K shares (8.4%) · Q4 2022. Average closing price $153.33 · Price range $138.31–$165.9944KsharessoldAdded 1.8M shares (372.7%) · Q1 2023. Average closing price $152.88 · Price range $144.61–$166.551.8MsharespurchasedSold 333K shares (14.7%) · Q2 2023. Average closing price $146.64 · Price range $132.51–$164.90333KsharessoldAdded 1.2M shares (61.9%) · Q3 2023. Average closing price $146.80 · Price range $133.59–$154.651.2MsharespurchasedSold 2.6M shares (83.1%) · Q4 2023. Average closing price $145.79 · Price range $137.60–$154.972.6MsharessoldSold 523K shares (98.9%) · Q1 2024. Average closing price $172.34 · Price range $159.82–$182.10523KsharessoldNew position of 247K shares · Q3 2024. Average closing price $186.63 · Price range $163.84–$199.35247KsharespurchasedAdded 471K shares (190.7%) · Q4 2024. Average closing price $183.86 · Price range $164.99–$203.87471KsharespurchasedAdded 1.1M shares (157.0%) · Q1 2025. Average closing price $194.40 · Price range $169.20–$216.661.1MsharespurchasedAdded 1.4M shares (76.1%) · Q2 2025. Average closing price $185.85 · Price range $170.16–$206.271.4MsharespurchasedSold 147K shares (4.5%) · Q3 2025. Average closing price $203.66 · Price range $184.85–$231.54147KsharessoldSold 2.4M shares (76.4%) · Q4 2025. Average closing price $227.94 · Price range $211.96–$244.382.4MsharessoldSold 243K shares (33.1%) · Q1 2026. Average closing price $221.79 · Price range $204.93–$236.19243Ksharessold← Earlier —1 sell
Average closing price · filing quarter
$221.79
Price range · filing quarter
$204.93 – $236.19

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −243K −$54M −33.1% 490K May 15, 2026
Q4 2025 Reduced −2.4M −$541M −76.4% 733K Feb 17, 2026
Q3 2025 Reduced −147K −$30M −4.5% 3.1M Nov 14, 2025
Q2 2025 Added +1.4M +$261M +76.1% 3.3M Aug 14, 2025
Q1 2025 Added +1.1M +$219M +157.0% 1.8M May 15, 2025
Q4 2024 Added +471K +$87M +190.7% 719K Feb 14, 2025
Q3 2024 New +247K +$46M 247K Nov 14, 2024
Q1 2024 Reduced −523K −$90M −98.9% 6K May 15, 2024
Q4 2023 Reduced −2.6M −$379M −83.1% 529K Feb 14, 2024
Q3 2023 Added +1.2M +$175M +61.9% 3.1M Nov 14, 2023
Q2 2023 Reduced −333K −$49M −14.7% 1.9M Aug 14, 2023
Q1 2023 Added +1.8M +$273M +372.7% 2.3M May 15, 2023
Q4 2022 Reduced −44K −$6.7M −8.4% 479K Feb 14, 2023
Q3 2022 Reduced −40K −$5.7M −7.0% 523K Nov 14, 2022
Q2 2022 Reduced −413K −$63M −42.3% 562K Aug 15, 2022
Q1 2022 Reduced −5K −$702K −0.5% 975K May 16, 2022
Q4 2021 Reduced −149K −$18M −13.2% 980K Feb 14, 2022
Q3 2021 Added +959K +$110M +563.4% 1.1M Nov 15, 2021
Q2 2021 Reduced −964K −$109M −85.0% 170K Aug 16, 2021
Q1 2021 First covered 1.1M May 21, 2021
Data through Q1 2026 · filed May 15, 2026
20 grouped rows from 20 quarters

More Griffin positions

Common questions

Does Ken Griffin own ABBV?

Yes. As of Q1 2026, Ken Griffin disclosed 490K shares of ABBV, worth $106M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ken Griffin buy ABBV?

Ken Griffin held ABBV since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ken Griffin sell ABBV?

The quarter-by-quarter table above shows each sale and reduction Ken Griffin disclosed in ABBV. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of ABBV does Ken Griffin own?

Ken Griffin disclosed 490K shares of ABBV as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ken Griffin pay for ABBV?

Ken Griffin's estimated average buy price for ABBV is $188.59, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.